Objectives During the COVID-19 pandemic, several studies described an increased chance
of developing pulmonary embolism (PE). Several scores have been used to predict the …

The coronavirus 2019 pandemic has affected many healthcare systems worldwide. While
acute respiratory distress syndrome (ARDS) has been well-documented in COVID-19, there …

Background Patients with COVID-19 infection are commonly reported to have an increased
risk of venous thrombosis. The choice of anti-thrombotic agents and doses are currently …

In April 2020, in response to the high thrombotic risk associated with COVID-19, the GIHP
and GFHT published proposals for the prevention of venous thromboembolism (VTE) and …

Background Sources of heterogeneity in venous thromboembolism (VTE) risk in COVID-19
are unclear and comparisons to other viruses are lacking. Objectives To describe VTE risk in …

Abstract In Coronavirus disease 2019 (COVID-19) subjects, recent evidence suggests the
presence of unique coagulation abnormalities. In this study, we performed clot waveform …

Severe Acute Respiratory Syndrome (SARS) Coronavirus (CoV)-2 is a recently identified
positive sense single-strand RNA (ssRNA) β-coronavirus. The viral spike proteins infect …

Objectives Coagulation dysfunction is an evident factor in the clinical diagnosis and
treatment of patients with coronavirus disease 2019 (COVID-19), appearing even in COVID …

Background Thrombosis is reported to occur more often among patients with COVID‐19
than otherwise expected in the setting of viral pneumonia and sepsis. Systemic inflammatory …

(1) Background: We aimed to describe the clinical and imaging characteristics of patients
diagnosed with pulmonary artery thrombosis (PAT) despite receiving anticoagulation with …